← brief for 2026-09-07 · Slowing decline

Clinical Severity of Diabetic Ketoacidosis by SGLT2 Inhibitors Use: A Retrospective Observational Study.

Key takeaways

SGLT2 inhibitors are diabetes drugs that also protect the kidneys and heart. A rare side effect is diabetic ketoacidosis, a dangerous build-up of acid in the blood. Researchers looked back at hospital records of people admitted with this condition and compared those on the drug with those who were not, to see if the drug users were sicker. This kind of look-back study shows a link at most, not proof of cause, and the abstract does not give the number of patients or the results.

Who did this work

Naaman M · Fisher-Negev T · Aharon-Hananel G · Harel T · Cahn A

Source

Article · PubMed, the drug frontier · 2026 Sep
https://pubmed.ncbi.nlm.nih.gov/42704622/